Apsara Biotechnology Research is an independent research provider focused on the global biotechnology sector. We provide a variety of equity research services to our clients, in both customized and subscription formats.
Our research team is headed by Yang Yu. Mr. Yu and his team have extensive experience examining biotechnology, healthcare and pharmaceutical investments. Prior to launching Apsara Biotechnology Research, Mr. Yu worked as a private consultant. Our expertise includes:
- Evaluation of public and private companies in the biotechnology, healthcare and pharmaceutical sectors, including their products and technologies, R&D pipeline, executive managers and business finances. We hope that our research-driven analysis can help our clients identify the leading technologies for long investments, as well as potential drug and business failures for short investments.
- Strategic development for biologics and pharmaceutical drugs with expertise in regulatory strategy, clinical trials, regulatory submissions, pharmaceutical sales and marketing strategy, regulatory auditing, and quality management.
If you are a prospective client or would like to contact Apsara Biotechnology Research about our products and services, please complete the following form. Thank you for your interest in Apsara.